Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Alumis Inc. Common Stock

ALMS•NASDAQ
Healthcare
Biotechnology
$27.41
$-1.80(-6.16%)
U.S. Market is Open • 12:24

Alumis Inc. Common Stock (ALMS) Stock Overview

Explore Alumis Inc. Common Stock’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap2.9B
P/E Ratio-12.01
EPS (TTM)$-2.15
ROE-0.76%
Fundamental Analysis

AI Price Forecasts

1 Month$27.46
3 Months$39.17
1 Year Target$9.43

ALMS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Alumis Inc. Common Stock (ALMS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 63.86, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $9.43.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -12.01 and a market capitalization of 2.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-4.23%
5-Day Change
4.48%
1-Month Change
7.33%
3-Month Change
304.19%
6-Month Change
534.24%
Year-to-Date (YTD) Change
212.17%
1-Year Change
445.22%
3-Year Change
110.30%
5-Year Change
110.30%
All-Time (Max) Change
110.30%

Contact Information

https://www.alumis.com
(650) 231-6625
280 East Grand Avenue, South San Francisco, CA, 94080

Company Facts

1,680 Employees
IPO DateFeb 22, 2021
CountryUS
Actively Trading

Frequently Asked Questions